Bought
Maintained
Sold
Other funds holding AMGN
BIT
BFA
UBS's AMGN Position: Q3 2014 in Review
UBS increased its Amgen (AMGN) stake by 186% in Q3 2014, buying an estimated $387M and bringing the position to 4,556,244 shares worth $640M. The position accounts for 0.47% of the portfolio, ranked #25.
UBS first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.
- UBS held 4,556,244 shares of Amgen worth $640M as of Q3 2014.
- UBS bought 2,962,203 Amgen shares in Q3 2014, an estimated $387M.
- Amgen made up 0.47% of UBS's portfolio in Q3 2014, its #25 holding.
- UBS first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
- 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.